• Episode 22 - Dr. Michael Hayden and PROOF-HD

  • Feb 1 2021
  • Durée: 58 min
  • Podcast

Episode 22 - Dr. Michael Hayden and PROOF-HD

  • Résumé

  • Dr. Michael Hayden, Chief Executive Officer for Prilenia Therapeutics, and a Killam Professor at the University of British Columbia, joined the HD Insights Podcast to discuss the PROOF-HD clinical study. Prilenia (https://www.prilenia.com) is sponsor for the currently active PROOF-HD trial, a global study evaluating the efficacy and safety of pridopidine in patients with early stage of Huntington disease. Dr. Hayden spoke about this new study's unique endpoint for total functional capacity. You will also want to hear his inspiring personal journey that led him into Huntington disease research growing up in South Africa.

    For more information on PROOF-HD, visit https://huntingtonstudygroup.org/proof-hd/.

    Voir plus Voir moins

Ce que les auditeurs disent de Episode 22 - Dr. Michael Hayden and PROOF-HD

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.